Kelleher Financial Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Hold
600
﹤0.01% 550
2026
Q1
$31.2K Hold
600
0.01% 433
2025
Q4
$24.4K Hold
600
0.01% 489
2025
Q3
$28.2K Buy
+600
New +$31.1K 0.01% 395

Other funds holding CNMD

Kelleher Financial Advisors's CNMD Position: Q2 2026 in Review

Kelleher Financial Advisors held its CONMED (CNMD) position steady in Q2 2026 at 600 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Kelleher Financial Advisors first reported a position in CNMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $31.2K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Kelleher Financial Advisors held 600 shares of CONMED worth $19.6K as of Q2 2026.
  • Kelleher Financial Advisors left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #550 holding.
  • Kelleher Financial Advisors first reported a position in CONMED in Q3 2025 and has held it in 4 quarters since.
  • Kelleher Financial Advisors's CONMED position peaked at $31.2K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.